| Literature DB >> 27855655 |
Abeer Fadda1, Fiza Butt2, Sara Tomei3, Sara Deola3, Bernice Lo3, Amal Robay4, Alya Al-Shakaki4, Noor Al-Hajri4, Ronald Crystal5, Marios Kambouris6,7, Ena Wang3, Francesco M Marincola3, Khalid A Fakhro3,4, Chiara Cugno8,9.
Abstract
BACKGROUND: Ligase IV syndrome, a hereditary disease associated with compromised DNA damage response mechanisms, and Urofacial syndrome, caused by an impairment of neural cell signaling, are both rare genetic disorders, whose reports in literature are limited. We describe the first case combining both disorders in a specific phenotype. CASEEntities:
Keywords: Case report; Immunodeficiency; LIG4; LRIG2; Microcephaly; Vesicoureteral reflux; Whole genome sequencing
Mesh:
Substances:
Year: 2016 PMID: 27855655 PMCID: PMC5114772 DOI: 10.1186/s12881-016-0346-7
Source DB: PubMed Journal: BMC Med Genet ISSN: 1471-2350 Impact factor: 2.103
Fig. 1a. Family pedigree: the proband is highlighted by the arrow; LIG4 and LRIG2 chromatograms are shown for the homozygous proband; (b). LIG4 protein domains: the Y438H mutation is located in the adenylation domain (modified from Chistiakov [21]); (c). Pictures of the patient showing generalized hyposomia, facial dysmorphic features, but not inverted smile, and nail dystrophy
Patient’s immunophenotype assessed by flow cytometry: counts of B-lymphocytes, T lymphocytes with CD4+ helper and CD8+ cytotoxic subsets, and NK cells
| T/B Lymphocytes and NK populations | ||||
|---|---|---|---|---|
| cells/μL | n.v. cells/μL | % | n.v. % | |
| CD3+ | 816 cells/μL | 700–4200 | 89.0 | 55–78 |
| CD4+ | 112 cells/μL | 500–2000 | 10.9 | 27–53 |
| CD8+ | 416 cells/μL | 300–1800 | 40.8 | 19–34 |
| CD19+ | 3 cells/μL | 200–1600 | 0.3 | 10–31 |
| CD56+ | 66 cells/μL | 90–900 | 8.1 | 4–26 |
| CD3 + CD4-CD8- | 37.3 | |||
| CD4/CD8 ratio | 0.26 | |||
Overview of LRIG2 deficient patients (new and literature)
| Patienta | Recessive mutations | Facial phenotype | Urinary tract phenotype | Constipation | Wilms tumour | Ref. | |
|---|---|---|---|---|---|---|---|
| Allele 1 | Allele 2 | ||||||
| F 1.1 | c.1230delA | c.1230delA | YES | YES | YES | NO | −17 |
| F 1.2 | c.1230delA | c.1230delA | YES | NO | NO | NO | −17 |
| F 2 | c.2088delC | c.1980–1981ins371 | YES | YES | YES | NO | −17 |
| F 3.1 | c.2125C > T | c.2125C > T | YES | YES | YES | YES | −17 |
| F3.2 | c.2125C > T | c.2125C > T | YES | YES | Not known | NO | −17 |
| NEW | c.2125C > T | c.2125C > T | NO | YES | NO | NO | This study |
| Hinman-Allen syndrome | c.1648C > T | c.2554A > T | NO | YES | NO | NO | −17 |
aNamed as reported in single publications
Overview of LIG4 syndrome patients (new and literature)
| Patienta | Recessive mutations | RS | Microcephaly | ID | Cytopenia | GR | DD | Malignancy | Other | Ref. | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Allele 1 | Allele 2 | ||||||||||
| 180BR | p.R278H | p.R278H | YES | NK | NO | NK | NK | NO | Leukemia | −5 | |
| 3703 | p.R814X | p.R814X | YES | YES | NK | YES | YES | YES | Leukemia | −8 | |
| X | p.M249V | p.K524 | YES | YES | Mild | YES | YES | YES | EBV- BCL | −6 | |
| 2303 | p.R580X | p.R814X | YES | YES | Mild | YES | YES | NK | MDS | Hypothiroidism, type 2 DM, hypogonadism | −9 |
| 99P0149 | p.G469E | p.R814X | YES | YES | Mild | YES | YES | YES | NO | Atypical bone maturation | −9 |
| Case 1 | p.delK588 | p.delK588 | ND | YES | Mild | YES | YES | NO | NO | −10 | |
| Case 2 | p.delK588 | p.delK588 | ND | YES | Mild | YES | YES | NO | NO | −10 | |
| 10 Patients(9 families) | p.R814X | Variable truncating mutations | YES | YES | Mild | YES | YES | 7 YES/ | NO | Skeletal abnormalities 6/10), primary ovarian failure (2/10), dysplastic kidney (2/10), anal atresia (1/10), corpus callosum dysgenesis (1/10) | −14 |
| 2304 | p.R580X | p.R814X | YES | YES | Mild | NK | NO | NK | NO | Hypothiroidism, amenorrea | −9 |
| 411BR | p.R278H | p.R278H | YES | NO | Mild | YES | NO | YES | NO | −9 | |
| P1 | p.H282L | p.K524 | YES | YES | SCID | YES | YES | NO | EBV- BCL | −7 | |
| Patient | S205L | K635R | YES | YES | SCID | YES | YES | YES | NO | Skeletal abnormalities, urethral valves, corpus callosum dysgenesis | −13 |
| P-1 | p.Q280R | p.K524 | YES | YES | SCID | NO | YES | NO | NO | −12 | |
| P-2 | p.Q280R | p.K524 | YES | YES | SCID | NO | YES | NK | NO | −12 | |
| P2 | p.H282L | p.K524 | YES | YES | SCID | NO | NO | YES | NO | −7 | |
| LIG4-1 | p.delQ433 | p.delQ433 | YES | NO | SCID | YES | NO | NO | NO | −11 | |
| NEW | p.Y438H | p.Y438H | ND | YES | YES | YES | YES | YES | NO | Skeletal abnormalities, nail dystrophy | This study |
GR Growth retardation, ID Immunodeficiency, DD Developmental delay, RS Radiosensitivity, NK Not known, ND Not determined, EBV-BCL EBV-associated B-cell lymphoma, DM Diabetes mellitus
aNamed as reported in the single publications
bNo association with the second mutation paired to p.R814X